# Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)

> **NCT00358878** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 463 (actual)

## Conditions studied

- Ascites
- Liver Cirrhosis

## Interventions

- **DRUG:** Satavaptan
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00358878
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 463 (ACTUAL)
- **Last updated:** 2016-05-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00358878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00358878, "Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00358878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*